Sevelamer HCL lowers the phosphorus concentration in the serum.

Sevelamer HCL is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis. It could be used also with calcium supplements, 1,25 – dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease. Νot Available Until 30/1/2015
Active ingredient Pharmaceutical form Package Therapeutic target
  • Sevelamer HCL
  • F.c. Tablets
  • 800mg
  • Hyperphosphatemia in Patients with Chronic Renal Failure

Other products in "International"